Hedge fund Magnetar Financial filed this week to reveal it sold over $514 million worth of CRWV stock. The 10% owner executed 168 separate transactions between April 22 and May 1, offloading more than 4.2 million shares. The scale of the exit stands out sharply for a company that only went public in March 2026.
Also filing this week, Bain Capital Life Sciences sold nearly $57 million in HTFL shares across three days. The private equity firm unloaded over 1.9 million shares in HeartFlow as the medical imaging company settles into public markets.
On the buy side, TORO CEO Petros Panagiotidis filed disclosures showing he purchased over $13.7 million of his own company's stock across three trades in late April. That level of personal conviction from a sitting CEO is hard to ignore.
CSGP founder and CEO Andrew Florance also filed a fresh purchase. He bought $2.4 million in CoStar Group shares on May 1. The filing landed today, making it one of the freshest C-suite buys on record.
HOMB Chairman and CEO John Allison put in buying Home BancShares stock in mid-April. The founder-led purchase signals continued confidence despite a cautious banking environment.
Mueller Industries CEO Gregory Christopher filed a $14.2 million sale of MLI stock last week. The chairman and CEO sold over 103,000 shares at roughly $137 each.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
